The AI engine is offline (last seen Aug 12, 05:02 UTC). Scores are shown as of their timestamps; new theses and refreshes are queued and run the moment it returns.

Macro

Search catalysts, news stories, and pressures, or browse the trust-weighted news feed below.

Home tech energy finance healthcare defense industrial consumer communication utilities real estate raw materials
← back
healthcare · sector mood
2002
year mood +0.04 · -0.10 to +0.31 across 12 mo
Monthly mood
bearish −1 +1 bullish
-0.5 -0.25 0 +0.25 +0.5 Jan Feb Mar Apr May Jun Jul +0.31 Aug -0.10 Sep Oct Nov Dec
month values ▾
JanFebMarAprMayJunJulAugSepOctNovDec
+0.10+0.10+0.10+0.00+0.00+0.18+0.31-0.10-0.10-0.10+0.00+0.00

The sector sentiment is neutral despite Pfizer’s $60 billion acquisition of Pharmacia, a move that signals confidence in large-scale consolidation and pipeline expansion. While the deal underscores continued strategic ambition in the pharmaceutical space, broader healthcare performance remains weighed by lackluster movement in other sub-sectors and no accompanying regulatory or reimbursement tailwinds. The positive impact of the merger is thus offset by overall stagnation across the sector.

How this mood is scored ▾
Each day the model reads that day's news for the sector and asks, as someone who owns assets or makes their living in it: how am I feeling this month, and why? The month's mood is that running answer, tied to the specific events driving it (the story shown above). It leans on trusted, higher-impact reporting, and on the prior month when a month is quiet, so one loud headline can't swing it. The read updates daily through the month; once a month ends, its mood is locked. This year is read live from the news the pipeline actually collected (hover a bar for its story count). · last computed Jul 06, 2026
Top healthcare stories of 2002
Jun
ImClone founder Waksal arrested; Martha Stewart drawn into trading scandal foxnews.com →

Federal agents charged Sam Waksal with insider trading ahead of the Erbitux rejection, and questions spread to celebrity friend Martha Stewart. The saga personified the insider-dealing outrage of the scandal era.

Jul
Pfizer to acquire Pharmacia in $60 billion stock deal upi.com →

Pfizer is acquiring rival Pharmacia in a $60 billion stock-for-stock transaction, combining two major pharmaceutical firms to strengthen global R&D and commercial scale. The merger, expected to yield $2.5 billion in annual cost savings by 2005, unites key patented drugs like Lipitor, Viagra, Celebrex, and Bextra, enhancing Pfizer's pipeline and market leadership. The deal follows Pharmacia's spin-off of Monsanto and positions Pfizer for long-term industry dominance amid rising R&D costs and demand for innovative therapies.